Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.040 | Mediating the relationship between pain intensity and adjustment in chronic pain: comparison between the roles of cognitive behavioural-based and contextual behavioural-based factors |
Dr. CHAN Anne Miu Han 陳妙嫻 |
| 2015.084 | Effects of combined repetitive transcranial magnetic stimulation and treadmill training on gait performance in Parkinson’s disease – a randomised controlled trial |
Dr. CHAN Anne Y.Y. 陳然欣 |
| 2012.364 | Hong Kong Spinocerebellar Ataxias Registry | Dr. CHAN Anne Y.Y. |
| 2012.511 | Identification of novel gene mutations that cause dominant spinocerebellar ataxias in Hong Kong | Dr. CHAN Anne Y.Y. |
| 2012.361 | Establishment of genetic basis for neurological disease by genetic screening and development of disease-specific induced pluripotent stem (iPS) cells from dermal fibroblasts in selected patients | Dr. CHAN Anne Y.Y. |
| 2014.420 | Physiotherapy ambulation training protocol for people with Parkinson's disease | Dr. CHAN Anne Yin Yan |
| 2013.602 | Reliability and Validity of the Chinese Version of the Unified Parkinson's Disease Rating Scale (UPDRS) in Patients with Parkinson's Diseases | Dr. CHAN Anne YY |
| 2012.028 | Identification of biomarkers of response and resistance to anti-angiogenic agents in nasopharyngeal cancer | Prof Chan Anthony |
| 2010.597 | Towards personalized cancer therapy: Single nucleotide polymorphisms of the DNA repair protein, Excision Repair Cross Complementation group 1 (ERCC1), in Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2012.268 | META-ANALYSIS OF CHEMOTHERAPY IN NASO-PHARYNX CARCINOMA - An update with trials up to 2010 | Professor Chan Anthony |
| 2014.408 | Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) | Prof. CHAN Anthony |
| 2016.472 | POOL-ANALYSIS OF INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA |
Prof. CHAN Anthony 陳德章 |
| 2008.559 | Elucidating the role of the metastasis-associated SLBLING protein osteopontin in nasopharyngeal cancer | Prof Chan Anthony |
| 2008.084 | Efficacy of Recombinant Epstein-Barr virus (EBV) Vaccine in Patients with Nasopharyngeal Cancer who had Residual EBV DNA Load after Conventional Therapy | Prof. CHAN Anthony |
| 2006.256 | Randomized Trial to Evaluate the Therapeutic Gain by Changing the Chemoradiotherapy from Concurrent-Adjuvant to Induction-Concurrent Sequence, and the Radiotherapy from Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2010.253 | Phase 2 Study of Axitinib in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2005.414 | A Multi-Center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabline and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy with or without Concurrent Cisplatin | Prof. CHAN Anthony |
| 2008.203 | Phase II Study of TAS-106 in Patients with Recurrent or Metastatic Head and Neck Cancer Refractory to Platinum Based Chemotherapy | Prof. Chan Anthony |
| 2007.198 | A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer | Prof. CHAN Anthony T. C. |
| 2006.024 | A Phase I Trial of 5-Azacitidine and Suberoylanilide Hydroxamic Acid in Patients with Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T Cell Lymphoma | Prof. CHAN Anthony T. C. |
| 2008.198 | A Phase 2, Randomized Trial of Chemoradiation with or without Panitumumab in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Prof. CHAN Anthony T.C. |
| 2000.447 | Pre and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases from Colorectal Origin Phase III Randomized Study | Prof. CHAN Anthony T.C. |
| 2019.001 | Survival analysis of germline polymorphism and prognosis of patients with NPC |
Prof. CHAN Anthony T.C. 陳德章 |
| 2018.372 | NEO-SPACE trial: Neoadjuvant Pembrolizumab-Gemcitabine-Cisplatin followed by Concurrent Pembrolizumab-Chemoradiation and Maintenance Pembrolizumab for Stage IVA Nasopharyngeal Cancer |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2019.553 | AXEL: Axitinib-Avelumab combination in recurrent or metastatic nasopharyngeal cancer: a multicenter phase 2 trial |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2013.295 | LUX-Head & Neck 3: A randomized, open label, phase III study to evaluate the efficacy and safety of oral afatinib (BIBW 2992) versus intravenous methotrexate in patients with recurrent and / or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy. | Prof. CHAN Anthony Tak Cheung |
| 2010.396 | A Proposed Histological Classification of Nasopharyngeal Carcinoma Based on Epithelial-Messenchymal Transition and Its Significance in Prognosis Prediction | Prof. Chan Anthony Tak Cheung |
| 2016.382 | Detection and isolation of circulating tumor cells from patients with nasopharyngeal carcinoma. |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2016.070 | A Two-arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475) Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122) |
Prof. CHAN Anthony Tak Cheung 陳德章敎授 |
| 2014.409 | An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Prof. CHAN Anthony Tak Cheung |
| 2009.572 | Clinical significance of the metastasis-associated protein osteopontin in naopharyngeal cancer | Professor Chan Anthony TC |
| 2004.024 | Identification of Serum Prognostic Proteomic Patterns in Nasopharyngeal Carcinoma Development of Clinical Assay Prototype with the Combined Use of SELDI-TOF Mass Spectrometry and Bioinformatic Analyses | Prof. CHAN Anthony TC |
| 2016.496 | CCCTC-binding factor (CTCF) in hepatocellular carcinoma: functional characterization of its role in tumorigenesis and its potential in targeted therapy. | Dr. CHAN Anthony Wing Hung |
| 2016.278 | Functional role of the gluconeogenesis regulatory enzyme, fructose-1,6-bisphosphatase-1 (FBP1), in hepatocarcinogenesis |
Dr. CHAN Anthony Wing Hung 陳永鴻 |
| 2024.268 | Single shot thoracic paravertebral block (TPVB) with dextran and magnesium compared to continuous TPVB in unilateral rib fracture - a randomised controlled non-inferiority trial | Dr. Chan Anyon |
| 2016.449 | To understand the attitudes of the public, patients receiving palliative care, their relatives and health professionals towards using Traditional Chinese Medicine treatment in Hong Kong Palliative care. |
Miss CHAN Audrey Ho Yan 陳可昕 |
| 2015.628 | Neonatal Behavioral Differences on Newborn Babies |
Ms. CHAN Barbara Chung Man 陳頌文 |
| 2023.359 | A multimedia method for pre-test genetic counseling in breast cancer patients – A pilot feasibility study | Prof. CHAN Carmen |
| 2007.374 | Quantitative assessment of optic disc morphology of non-glaucomatous optic neuropathy | Dr. CHAN Carmen Kar Mun |
| 2013.133 | Developing a conceptual model to predict the acceptance and completion of advance directives in the Chinese community in Hong Kong: A population-based survey | Prof. CHAN Carmen W. H. |
| 2010.182 | A conceptual model of self-care and symptom management following cancer treatment for Hong Kong Chinese | Prof Chan Carmen W.H. |
| 2008.220 | A Survey on Health Status of Childhood Cancer Survivors | Prof Chan Carmen W.H. |
| 2008.115 | A Pilot Study to Assess the Feasibility and Acceptability of Using the Electronic Self Report Assessment - Cancer (ESRA-c) amongst Chinese Oncology Patients | Prof Chan Carmen W.H. |
| 2024.148 | The conflict status of fertility preservation decision-making and their impacts on decision results in childbearing-age female patients with cancer | Prof. CHAN Carmen W.H. |
| 2016.560 | Hong Kong Nurses perceptions of optimal end of life care in hospitals |
Prof. CHAN Carmen W.H. 陳葉詠嫻 |
| 2016.321 | Early-life gut microbiome and environmental factors in the development of eczema in Chinese children: a birth cohort study |
Prof. CHAN Carmen W.H. 陳葉詠嫻 |
| 2016.554 | Advancing the science of personalized health care: A prospective study to uncover the role of predictive biomarkers in tamoxifen-related endocrine symptoms and drug adherence based on genetic polymorphisms in breast cancer patients in Hong Kong |
Prof. CHAN Carmen W.H. 陳葉詠嫻 |
| 2024.018 | Effectiveness of multi-media genetic counselling method and the factors influencing the decision-making process for breast cancer genetic testing | Prof. CHAN Carmen WH |
| 2024.391 | Predictors of long-term inappropriate Proton Pump Inhibitor use in the Elderly | Dr. CHAN Chak Hei |
| 2012.262 | Prevalence of psychiatric morbidity in Chinese subjects with gender identity disturbances in Hong Kong | Dr Chan Cheuk Chi |
Page 51 of 254.